SEC Filing Summary: Cerecor Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed by Cerecor Inc. on August 2, 2021. The filing serves as a current report to announce the Company's financial results for the quarter ended June 30, 2021, and to disclose a recent debt financing activity. The Company is incorporated in Delaware and trades on the Nasdaq Capital Market under the symbol CERC.
Key Financial Metrics and Events
- Debt Financing: The Company announced a drawdown of $10.0 million under its debt financing agreement with Horizon Technology Finance.
- Financial Results: The filing references a press release (Exhibit 99.1) containing the detailed results of operations and financial condition for the quarter ended June 30, 2021.
- Liquidity: The debt drawdown announcement included the Company's cash and cash equivalents as of June 30, 2021, though specific balance sheet figures are not detailed in the 8-K text itself.
Material Changes and Comparisons
The filing text does not provide specific numerical comparisons of revenue, profit, or margins versus the prior comparable period. It directs investors to the attached press release (Exhibit 99.1) for the full quarterly results and the press release (Exhibit 99.2) for details on the debt drawdown.
Guidance, Outlook, and Risks
The 8-K text does not contain specific management commentary, forward-looking guidance, or a detailed discussion of risks and contingencies. It explicitly states that the information in Item 2.02 and the attached exhibits shall not be deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference in other filings except as expressly set forth.
Key Facts for Investor Verification
- Verify the specific revenue, net loss, and cash burn figures in the attached Exhibit 99.1 (Press Release dated August 2, 2021).
- Confirm the exact cash and cash equivalents balance as of June 30, 2021, referenced in Exhibit 99.2.
- Review the terms of the debt financing agreement with Horizon Technology Finance to understand repayment obligations and covenants.
- Note that the filing references Avalo Therapeutics, Inc. in the metadata request, but the actual filing is for Cerecor Inc.; ensure the correct entity is being analyzed.